CS logo
small CS logo
Russian Academy of Medical Sciences Institution

Moscow, Russian Federation

About Russian Academy of Medical Sciences Institution


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Russian Academy of Medical Sciences Institution


During the past decade, Russian Academy of Medical Sciences Institution conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Russian Academy of Medical Sciences Institution" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Russian Academy of Medical Sciences Institution


According to Clinical.Site data, the most researched conditions in "Russian Academy of Medical Sciences Institution" are "B-Cell Chronic Lymphocytic Leukemia" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Russian Academy of Medical Sciences Institution" in a lesser frequency.

Clinical Trials Intervention Types at Russian Academy of Medical Sciences Institution


Most popular intervention types in "Russian Academy of Medical Sciences Institution" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Lenalidomide" (2 trials), "Placebo" (2 trials), "Chlorambucil" (1 trials), "Enzalutamide" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Russian Academy of Medical Sciences Institution


The vast majority of trials in "Russian Academy of Medical Sciences Institution" are 2 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Russian Academy of Medical Sciences Institution


Currently, there are NaN active trials in "Russian Academy of Medical Sciences Institution". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Russian Academy of Medical Sciences Institution, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Russian Academy of Medical Sciences Institution, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".